Both companies will expand their cooperation through the distribution of medical cannabis products in the highly attractive Czech and Swiss markets
DUSSELDORF, Germany, BARCELONA, Spain and TEL AVIV, Israel, Oct. 6, 2022 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), and Panaxia (TASE: PN…….